Amlodipine

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• FDA Prescribing Information: Amlodipine (Norvasc) — dihydropyridine CCB; peripheral edema; gingival hyperplasia; CCB OD management HIET/lipid emulsion; pediatric hypertension ≥6yr; veterinary feline approval 0.625mg; long half-life OD delayed onset (2023) REGULATORY · 2023
• ASPCA Animal Poison Control Center: Cardiac Drug Toxicosis in Pets — statin myopathy in cats; beta-blocker bradycardia dogs; CCB toxicity (amlodipine/diltiazem); ACE inhibitor renal effects; warfarin anticoagulant; furosemide; toxic dose thresholds (2023) VETERINARY · 2023
• identity database ECHA CHEM, Download all substances: REACH registrations (ECHA's own list of REACH-registered substances) REGULATORY · 2026
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID7022596 (Amlodipine) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.